Stephen Townley Holgate
Holgate, Stephen T.
Holgate, S. T.
Holgate, S. T., 1947-
Holgate, Stephen T., 1947-
Holgate, S. T. (Stephen T.)
VIAF ID: 12415200 (Personal)
Permalink: http://viaf.org/viaf/12415200
Preferred Forms
-
-
-
-
- 100 1 _ ‡a Holgate, S. T
-
- 100 1 _ ‡a Holgate, S. T.
-
-
- 100 1 0 ‡a Holgate, S. T. ‡d 1947-
- 100 1 _ ‡a Holgate, S. T. ‡d 1947-
- 100 1 _ ‡a Holgate, S. T. ‡q (Stephen T.)
-
-
-
- 100 1 _ ‡a Holgate, Stephen T.
-
-
-
- 100 1 _ ‡a Holgate, Stephen T.
- 100 1 _ ‡a Holgate, Stephen T. ‡d 1947-
- 100 1 _ ‡a Holgate, Stephen T. ‡d 1947-
-
- 100 0 _ ‡a Stephen Townley Holgate
4xx's: Alternate Name Forms (28)
5xx's: Related Names (1)
Works
Title | Sources |
---|---|
Air pollution and health | |
Alergia | |
Allergologie le Middleton | |
Allergy | |
Are long-acting β2-agonists safe in the treatment of asthma | |
Asma y rinitis | |
Asthma and Allergic Diseases physiology, immunopharmacology, and treatment | |
Asthma and rhinitis | |
Asthma : critical debates | |
Biodiversity under threat | |
Cellular and molecular targets in allergy and clinical immunology : proceedings of the 26th Symposium of the Collegium Internationale Allergologicum | |
Difficult asthma | |
Fast Facts : asthma | |
Future perspectives | |
The Genetics of asthma | |
H1-antihistamine efficacy | |
The hereditary basis of allergic diseases | |
Immunopharmacology of the respiratory system | |
Inflammatory mechanisms in asthma | |
Inhaled adenosine and guanosine on airway resistance in normal and asthmatic subjects. 1983. | |
Mast cells, mediators and disease | |
Proceedings of the 4th international symposium on basic appraoch to allergic rhinitis : Tokyo, 10-11 February 2001 : allergy from the nose to the lungs | |
Rhinovirus infection increases 5-lipoxygenase and cyclooxygenase-2 in bronchial biopsy specimens from nonatopic subjects | |
Risk of first-generation H(1)-antihistamines: a GA(2)LEN position paper | |
Role of carbohydrates in repair of human respiratory epithelium using an in vitro model | |
Role of deficient type III interferon-λ production in asthma exacerbations | |
The role of histamine in asthma | |
The role of IgE in allergen-induced inflammation and the potential for intervention with a humanized monoclonal anti-IgE antibody | |
Role of leukotrienes in exercise-induced asthma. Inhibitory effect of ICI 204219, a potent leukotriene D4 receptor antagonist | |
The role of the airway epithelium and its interaction with environmental factors in asthma pathogenesis | |
Roles of cysteinyl leukotrienes in airway inflammation, smooth muscle function, and remodeling | |
Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial | |
Safety and tolerability of omalizumab | |
Sensitivity to Parietaria pollen in the Southampton area as determined by skin-prick and RAST tests. | |
Severe asthma in adults: what are the important questions? | |
The significance of antinuclear and DNA antibodies in cryptogenic fibrosing alveolitis | |
Slow-reacting substance of anaphylaxis to leukotrienes | |
Specific antagonism of adenosine-induced bronchoconstriction in asthma by oral theophylline | |
SRS-A to leukotrienes : the dawning of a new treatment | |
ß₂-mimetyki : paradoks w leczeniu astmy | |
Stimulation of human airway epithelial cells by platelet activating factor (PAF) and arachidonic acid produces 15-hydroxyeicosatetraenoic acid (15-HETE) capable of contracting bronchial smooth muscle | |
Stratified approaches to the treatment of asthma | |
Structural and secretory characteristics of bovine lung and skin mast cells: evidence for the existence of heterogeneity | |
Studies of cellular mechanisms for the generation of superoxide by guinea-pig eosinophils and its dissociation from granule peroxidase release | |
Summary of recommendations for the design of clinical trials and the registration of drugs used in the treatment of asthma | |
Susceptibility genes in severe asthma | |
Targeting adenosine receptors: novel therapeutic targets in asthma and chronic obstructive pulmonary disease | |
Temporal association between pulmonary inflammation and antioxidant induction following hyperoxic exposure of the preterm guinea pig. | |
Terfenadine | |
Therapy and prevention | |
Toll-like receptor polymorphisms and allergic disease: interpreting the evidence from genetic studies | |
Transforming growth factor-beta promotes rhinovirus replication in bronchial epithelial cells by suppressing the innate immune response | |
Tratamiento anti-inmunoglobulina E con omalizumab en enfermedades alérgicas: una actualización sobre actividad antiinflamatoria y e | |
Treatable traits: toward precision medicine of chronic airway diseases | |
Trials and tribulations in identifying new biologic treatments for asthma | |
Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed | |
Tumor necrosis factor alpha (TNF-α) autoregulates its expression and induces adhesion molecule expression in asthma | |
The use of omalizumab in the treatment of severe allergic asthma: A clinical experience update | |
Use of ultramolecular potencies of allergen to treat asthmatic people allergic to house dust mite: double blind randomised controlled clinical trial | |
Variability and lack of predictive ability of asthma end-points in clinical trials | |
Wheal-and-flare responses to intradermally injected adenosine 5'-monophosphate, hypertonic saline, and histamine: comparison of atopic and nonatopic subjects | |
Your guide to asthma | |
慢性喘息 Chronic asthma |